Should You Buy Moderna Before Feb. 13?
(NASDAQ: MRNA) has been on fire this year, with the biotech's shares up by 39% through Feb. 6. This isn't due to the company's financial results. Moderna has yet to release its fourth-quarter 2025 update. That's coming up on Feb. 13.
And although it provided guidance for 2025, that was months ago and wasn't nearly spectacular enough to jolt the stock this much. What's driving Moderna's performance in 2026? And should investors buy the stock before its next quarterly update? Let's take a look.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Stock
€52.18
0.680%
Our community is currently high on Moderna Inc. with 11 Buy predictions and 8 Sell predictions.
On the other hand, the target price of 21 € is below the current price of 52.18 € for Moderna Inc., so the potential is actually -59.75%.
